论文信息 - JAK inhibition for CD3- CD4+ lymphocytic-variant hypereosinophilic syndrome. - 字舞流文

JAK inhibition for CD3- CD4+ lymphocytic-variant hypereosinophilic syndrome.

M. Hunault-Berger | Yves Renaudineau | F. Vergez | J. Kahn | S. Faguer | M. Groh | N. Duployez | Carle Paul | G. Lefèvre